MindWalk Holdings (HYFT) Return on Capital Employed (2021 - 2026)
MindWalk Holdings (HYFT) reported Return on Capital Employed of 20777.5% for Q1 2026, down 2067030.0% year-over-year from N/an in Q1 2025, and down 44.84% quarter-over-quarter from 14345.52% in Q4 2025.
MindWalk Holdings (HYFT) Return on Capital Employed (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Return on Capital Employed data on file, last reported at 20777.5% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 20777.5%, down 2067030.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 20777.5% (down 2067030.0% YoY), and the FY2025 annual result was 0.08%, up 5339.0% from the prior year.
- Return on Capital Employed eased to 20777.5% in Q1 2026 per HYFT's latest filing, from 14345.52% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 5.32% in Q3 2022 and troughed at 20777.5% in Q1 2026.
- A 5-year average of 2098.49% and a median of 23.56% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2026: Return on Capital Employed jumped 555 bps in 2022, then tumbled 2067030 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 5.99% in 2022, then plunged by 294 bps to 23.56% in 2023, then sank by 133 bps to 54.86% in 2024, then tumbled by 26048 bps to 14345.52% in 2025, then sank by 45 bps to 20777.5% in 2026.
- Business Quant data shows HYFT's Return on Capital Employed at 20777.5% in Q1 2026, 14345.52% in Q4 2025, and 95.82% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -107.40% |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -50.43% |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -20,777.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -20,777.50% |
| Oct 31, 2025 | -14,345.52% |
| Jul 31, 2025 | -95.82% |
| Apr 30, 2025 | -69.21% |
| Jan 31, 2025 | -107.19% |
| Oct 31, 2024 | -54.86% |
| Jul 31, 2024 | -59.44% |
| Apr 30, 2024 | -46.81% |
| Jan 31, 2024 | -22.07% |
| Oct 31, 2023 | -23.56% |
| Jul 31, 2023 | -18.60% |
| Apr 30, 2023 | -17.83% |
| Jan 31, 2023 | -11.96% |
| Oct 31, 2022 | -5.99% |
| Jul 31, 2022 | -5.32% |
| Apr 30, 2022 | -6.54% |
| Jan 31, 2022 | -6.08% |
| Oct 31, 2021 | -7.80% |
| Jul 31, 2021 | -10.87% |